Infectious diseases continue to pose significant challenges to public health systems worldwide, particularly in settings where resources, surveillance ...
Post-marketing data chart immunotherapy performance in early-onset Alzheimer’s. The antibodies lowered amyloid and slowed functional decline. However, tangles continued to form. “These results offer ...
Enhertu showed better outcomes in HR-positive, HER2-negative breast cancer, while Trodelvy was more effective in HR-negative, HER2-null tumors when used first. Real-world data from over 4,000 patients ...
The last time I wrote about Mind Medicine (MindMed) Inc. (MNMD) was when it was gearing up to report results from a phase 2b study known as MMED008, which was using its drug MM120 for the treatment of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results